Free Trial

Cannabis Stocks To Watch Now - November 9th

Trulieve Cannabis logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Trulieve Cannabis, Aurora Cannabis, and Tilray Brands were identified by MarketBeat as cannabis stocks with the highest dollar trading volume in recent days.
  • In Monday trading, Trulieve fell $0.51 to $11.05, Aurora edged up $0.01 to $5.25, and Tilray declined $0.04 to $2.88.
  • The companies operate across cannabis cultivation, production, and sales, with Trulieve focused on U.S. markets, Aurora active in Canada and internationally, and Tilray selling across numerous countries.
  • Five stocks we like better than Trulieve Cannabis.

Trulieve Cannabis, Aurora Cannabis, and Tilray Brands are the three Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are shares of publicly traded companies involved in the cannabis industry, such as growers, retailers, processors, or companies supplying related products and services. Their performance can be influenced by industry growth, company results, and changing laws and regulations. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.

Trulieve Cannabis (TRLV)

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia, as well as directly to patients through home delivery.

TRLV stock traded down $0.51 during trading on Monday, hitting $11.05. The stock had a trading volume of 713,992 shares, compared to its average volume of 981,495. The company has a debt-to-equity ratio of 0.45, a current ratio of 5.52 and a quick ratio of 3.65. Trulieve Cannabis has a twelve month low of $4.62 and a twelve month high of $13.28. The stock has a market cap of $2.13 billion and a PE ratio of 100.22. The business's 50-day moving average price is $11.21.

Read Our Latest Research Report on TRLV

Aurora Cannabis (ACB)

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.

Shares of Aurora Cannabis stock traded up $0.01 during mid-day trading on Monday, reaching $5.25. 1,184,890 shares of the stock traded hands, compared to its average volume of 1,179,101. The business has a 50-day moving average of $4.15 and a 200 day moving average of $3.57. Aurora Cannabis has a fifty-two week low of $2.56 and a fifty-two week high of $6.36. The stock has a market capitalization of $344.70 million, a PE ratio of -5.35 and a beta of 0.65. The company has a quick ratio of 2.60, a current ratio of 5.00 and a debt-to-equity ratio of 0.03.

Read Our Latest Research Report on ACB

Tilray Brands (TLRY)

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

Shares of NASDAQ TLRY traded down $0.04 during midday trading on Monday, hitting $2.88. The stock had a trading volume of 1,549,764 shares, compared to its average volume of 4,273,023. The company has a quick ratio of 1.11, a current ratio of 1.88 and a debt-to-equity ratio of 0.17. The stock has a 50 day simple moving average of $3.59 and a 200-day simple moving average of $5.34. The company has a market capitalization of $424.90 million, a PE ratio of -2.05 and a beta of 2.04. Tilray Brands has a 1 year low of $2.48 and a 1 year high of $15.70.

Read Our Latest Research Report on TLRY

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Trulieve Cannabis Right Now?

Before you consider Trulieve Cannabis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trulieve Cannabis wasn't on the list.

While Trulieve Cannabis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines